Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junqi Wu

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Cancer Immunology, Immunotherapy : CII|September 20, 2022
Correction to: The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center studyChongwu Li, Junqi Wu, Long Jiang, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2022
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center studyChongwu Li, Junqi Wu, Long Jiang, et al.
Cell|August 29, 2025
Stereo-seq V2: Spatial mapping of total RNA on FFPE sections with high resolutionYu Zhao, Young Li, Ying He, et al.
Cell|March 27, 2025
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancerZedao Liu, Zhenlin Yang, Junqi Wu, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Cancer Immunology, Immunotherapy : CII|September 20, 2022
Correction to: The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center studyChongwu Li, Junqi Wu, Long Jiang, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2022
The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center studyChongwu Li, Junqi Wu, Long Jiang, et al.
Cell|August 29, 2025
Stereo-seq V2: Spatial mapping of total RNA on FFPE sections with high resolutionYu Zhao, Young Li, Ying He, et al.
Cell|March 27, 2025
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancerZedao Liu, Zhenlin Yang, Junqi Wu, et al.
Pageof 10